199 related articles for article (PubMed ID: 34238603)
21. Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system.
Sivarajah M; Beninato T; Fahey TJ
Surgery; 2020 Jan; 167(1):211-215. PubMed ID: 31564486
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.
Ayas NT; FitzGerald JM; Fleetham JA; White DP; Schulzer M; Ryan CF; Ghaeli R; Mercer GW; Cooper P; Tan MC; Marra CA
Arch Intern Med; 2006 May; 166(9):977-84. PubMed ID: 16682570
[TBL] [Abstract][Full Text] [Related]
23. Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program - A Markov Model.
Perraudin C; Le Vaillant M; Pelletier-Fleury N
PLoS One; 2013; 8(6):e63894. PubMed ID: 23805176
[TBL] [Abstract][Full Text] [Related]
24. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
[TBL] [Abstract][Full Text] [Related]
26. Primary aldosteronism: an update on screening, diagnosis and treatment.
Rossi GP; Pessina AC; Heagerty AM
J Hypertens; 2008 Apr; 26(4):613-21. PubMed ID: 18327065
[TBL] [Abstract][Full Text] [Related]
27. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam.
Nguyen TP; Wright EP; Nguyen TT; Schuiling-Veninga CC; Bijlsma MJ; Nguyen TB; Postma MJ
PLoS One; 2016; 11(5):e0155699. PubMed ID: 27192051
[TBL] [Abstract][Full Text] [Related]
29. Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities.
Turcu AF; Nhan W; Grigoryan S; Zhang L; Urban C; Liu H; Holevinski L; Zhao L
J Am Heart Assoc; 2022 Jul; 11(14):e025952. PubMed ID: 35861830
[TBL] [Abstract][Full Text] [Related]
30. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.
Pedrosa RP; Drager LF; Gonzaga CC; Sousa MG; de Paula LK; Amaro AC; Amodeo C; Bortolotto LA; Krieger EM; Bradley TD; Lorenzi-Filho G
Hypertension; 2011 Nov; 58(5):811-7. PubMed ID: 21968750
[TBL] [Abstract][Full Text] [Related]
31. Who needs to be screened for primary aldosteronism?
Huang WC; Liu FH; Cheng HM; Tsai YC; Huang YT; Lai TS; Lin YH; Wu VC; Kao HL; Jia-Yin Hou C; Wu KD; Chen ST; Er LK
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S82-S90. PubMed ID: 37633770
[TBL] [Abstract][Full Text] [Related]
32. Prospective Screening for Primary Aldosteronism in Patients With Suspected Obstructive Sleep Apnea.
Chee MR; Hoo J; Libianto R; Gwini SM; Hamilton G; Narayan O; Young MJ; Fuller PJ; Yang J
Hypertension; 2021 Jun; 77(6):2094-2103. PubMed ID: 33896193
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation.
Ankcorn MJ; Tedder RS; Cairns J; Sandmann FG
Value Health; 2020 Mar; 23(3):309-318. PubMed ID: 32197726
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of primary aldosteronism.
Mulatero P; Monticone S; Bertello C; Tizzani D; Iannaccone A; Crudo V; Veglio F
Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):188-93. PubMed ID: 20389241
[TBL] [Abstract][Full Text] [Related]
35. Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
Loh HH; Sukor N
Front Endocrinol (Lausanne); 2022; 13():976979. PubMed ID: 36246876
[TBL] [Abstract][Full Text] [Related]
36. Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.
Sharples L; Glover M; Clutterbuck-James A; Bennett M; Jordan J; Chadwick R; Pittman M; East C; Cameron M; Davies M; Oscroft N; Smith I; Morrell M; Fox-Rushby J; Quinnell T
Health Technol Assess; 2014 Oct; 18(67):1-296. PubMed ID: 25359435
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting.
Pietzsch JB; Richter AK; Randerath W; Steffen A; Liu S; Geisler BP; Wasem J; Biermann-Stallwitz J
Respiration; 2019; 98(1):38-47. PubMed ID: 30923287
[TBL] [Abstract][Full Text] [Related]
38. The Cost-Effectiveness of Dual Mobility Implants for Primary Total Hip Arthroplasty: A Computer-Based Cost-Utility Model.
Barlow BT; McLawhorn AS; Westrich GH
J Bone Joint Surg Am; 2017 May; 99(9):768-777. PubMed ID: 28463921
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
40. The Potential Role of Primary Care in Case Detection/Screening of Primary Aldosteronism.
Kline GA; Prebtani APH; Leung AA; Schiffrin EL
Am J Hypertens; 2017 Nov; 30(12):1147-1150. PubMed ID: 28992276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
